Drugs / Qi Dong Yi Xin Granules
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT07508618 | Feb 2026 → Aug 2027 expected | persistent atrial fibrillation | Sir Run Run Shaw Hospital | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Qi Dong Yi Xin Granules | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07508618 ↗ |
| Route | Oral | “they will receive oral Qidong Yixin Granules” NCT07508618 ↗ |